期刊文献+

乏氧诱导因子-1α在鼻咽癌细胞表达及其与预后的关系 被引量:2

Expression of hypoxia inducible factor-1 alpha in nasopharyngeal cancer cells and its relationship with disease prognosis
下载PDF
导出
摘要 目的:观察乏氧诱导因子-1α( HIF-1α)在鼻咽癌细胞中的表达情况及其与预后的关系。方法通过治疗前检测200例鼻咽癌患者HIF-1α的表达情况,并分析阳性、阴性表达组治疗疗效来研究其与鼻咽癌预后的关系。结果200例鼻咽癌患者中 HIF-1α表达阳性者151例(75.5%),表达阴性者49例(24.5%)。Ⅰ、Ⅱ期表达阴性、阳性患者的疗效比较差异无统计学意义。Ⅲ~Ⅳa期患者表达阳性者的完全缓解率(85.9%、80.4%)低于表达阴性者(91.7%、84.6%),差异有统计学意义( P=0.032, P=0.041),2年局控率表达阳性者(74.6%、69.6%)低于表达阴性者(87.5%、76.9%),差异有统计学意义(P=0.021、P=0.035),2年生存率表达阳性者(84.5%、76.1%)低于表达阴性患者(95.8%、84.6%),差异有统计学意义( P=0.037、P=0.042)。结论大部分鼻咽癌患者呈现HIF-1α表达阳性,对于Ⅲ~Ⅳa期患者HIF-1α表达阳性与不良预后相关。 Objective To evaluate the expression of hypoxia-inducible factor-1 alpha ( HIF-1α) in nasopharyngeal cancer cells and its relationship with disease prognosis. Methods 200 patients with nasopharyngeal carcinoma( NPC) in our hospital were collected. The expression of HIF-1αwas detected by immunohistochemistry. The relationship of the HIF-1α expression with disease prognosis was analyzed. Results The number of HIF-1α positive expression was 151 cases ( 75. 5%) , and the number of HIF-1αnegative expression was 49 cases ( 24. 5%) . For stage Ⅰ and Ⅱ patients, the curative effects was no difference between HIF-1α positive and negative expression groups. For stage Ⅲ and Ⅳa patients, the complete tumor regression rate in HIF-1α positive and negative expression groups after treatment was (85. 9%and 80.4%) and(91.7%and 84.6%),respectively,and the difference was statistically significant. The local control rate after 2 years of treatment in HIF-1α positive group ( 74. 6% and 69. 6%) was significantly lower than HIF-1α negative expression group(87.5% and 76.9%). The survival rate after 2 years of treatment in HIF-1α positive expression group ( 84. 5% and 76. 1%) was significantly lower than HIF-1αnegative expression group(95.8%and 84.6%). Conclusion HIF-1αis positively expressed in most of NPC,which is correlated with poor prognosis of stage Ⅲ and Ⅳa patients.
出处 《广东药学院学报》 CAS 2014年第4期501-504,共4页 Academic Journal of Guangdong College of Pharmacy
关键词 乏氧诱导因子-1Α 鼻咽癌细胞 表达 预后 HIF-1 alpha nasopharyngeal cancer cell expression prognosis
  • 相关文献

参考文献11

  • 1HARRIS A L. Hypoxia: a key regulatory factor in turnout growth [J]. Nat Rev Cancer, 2002,2 ( 5 ) : 38-47.
  • 2吴德华,朱晓霞,张洪波,陈龙华.HIF-1α基因表达沉默对肝癌细胞的放射增敏作用[J].中国肿瘤临床,2009,36(2):110-113. 被引量:10
  • 3MAZZONE M, LEITE R, DETFORI D,et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization[ J ] .Cell, 2009, 136 (5) :839-851.
  • 4ZHONG H, de MARZO A M, LAUGHER E, et al. Overexpression of hypoxia-inducible factor l alpha in conunon human cancer and their metastases [J]. Cancer Res, 1999,59(22) :5830-5835.
  • 5BRAHIMI-YIORN C, POUYSSEGUR J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion[J] .Bull Cancer,2006,93(8) :E73-E80.
  • 6FYLES A, MILOSEVIC M, HEDLEY D, et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer [J].J Clin Oncol, 2002, 20(3) :680-687.
  • 7ZHONG H, de MARZO A M, LAUGHNER E, et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases [J]. Cancer Res, 1999,59(22) :5830-5835.
  • 8KOSHIJI M, KAGEYAMA Y, PETE E A, et al. HIF-1α induces cell cycle arrest by functionally counteracting Myc [J]. EMBO J, 2004,23 ( 9): 1949-1956. MELILLO G. Inhibiting hypoxia-inducible factor 1 for cancer therapy [ J ]. Mol Cancer Res, 2006,4 ( 9 ) : 601- 605.
  • 9MELILLO G. Inhibiting hypoxia-indu(fihle factor 1 for cancer therapy [J]. Mol Cancer Res, 2006,4 ( 9 ) : 601- 605.
  • 10莫立根,罗元,邝国乾,韦正波.HIF-1α在鼻咽癌组织中表达及意义[J].现代肿瘤医学,2007,15(1):19-21. 被引量:10

二级参考文献23

  • 1任瑞美,于金明,孙新东,张建东,宋现让,柳永蕾,尹勇.RNA干扰HIF-1α增强人肺腺癌SPCA-1细胞放射敏感性的研究[J].中华放射肿瘤学杂志,2005,14(6):503-506. 被引量:8
  • 2莫立根,罗元,邝国乾,韦正波.HIF-1α在鼻咽癌组织中表达及意义[J].现代肿瘤医学,2007,15(1):19-21. 被引量:10
  • 3Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation[J]. Mol Cell Biol, 1992, 12(12): 5447--5454.
  • 4Brahimi-Horn C, Pouyssegur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion[J]. Bull Cancer, 2006, 93(8): E73-E80.
  • 5Vaupel P. The role of hypoxia-induced factors in tumor progression[J]. Oncologist, 2004, 9 Suppl 5: 10--17.
  • 6Song X, Liu X, Chi W, et al. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF--lalpha gene[J]. Cancer Chemother Pharmacol. 2006, 58(6): 776-784.
  • 7Weinmann M, Belka C, Plasswilm L. Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours [J]. Onkologie, 2004, 27(1): 83-90.
  • 8Melillo G. Inhibiting hypoxia-inducible factor 1 for cancer therapy[J]. Mol Cancer Res, 2006, 4(9): 601-605.
  • 9Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression[J]. Nature, 2006, 441 (7092): 437-443.
  • 10Moeller BJ, Dreher MR, Rabbani ZN, et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity[J]. Cancer Cell, 2005, 8 (2): 99-110.

共引文献33

同被引文献24

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部